Long-Term Immunogenicity and in Vitro Prophylactic Protective Efficacy of M. Tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ As a Boosting Vaccine for BCG.
ACS Infectious Diseases（2023）
Key words
tuberculosis,subunit vaccine,DR2/DIMQ,adjuvant,memory T cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined